S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
LON:BVXP

Bioventix (BVXP) Share Forecast, Price & News

GBX 3,890
+25.00 (+0.65%)
(As of 04:17 AM ET)
Compare
Today's Range
3,865
▼
3,890
50-Day Range
3,706
▼
3,930
52-Week Range
3,250
▼
4,350
Volume
450 shs
Average Volume
6,909 shs
Market Capitalization
£203.06 million
P/E Ratio
2,431.25
Dividend Yield
3.50%
Price Target
N/A
ProfileChartCompetitorsDividendInsider TradesHeadlines

BVXP stock logo

About Bioventix (LON:BVXP) Stock

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.

BVXP Price History

BVXP Stock News Headlines

September 30, 2023 | finance.yahoo.com
BiVictriX Therapeutics Plc (BVX.L)
September 28, 2023 | americanbankingnews.com
Bioventix (LON:BVXP) Share Price Crosses Above 50 Day Moving Average of $3,797.34
October 3, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
September 26, 2023 | finance.yahoo.com
If EPS Growth Is Important To You, Bioventix (LON:BVXP) Presents An Opportunity
August 5, 2023 | finance.yahoo.com
With 63% institutional ownership, Bioventix PLC (LON:BVXP) is a favorite amongst the big guns
May 10, 2023 | finance.yahoo.com
Investors in Bioventix (LON:BVXP) have seen respectable returns of 76% over the past five years
April 19, 2023 | finance.yahoo.com
Do Bioventix's (LON:BVXP) Earnings Warrant Your Attention?
March 30, 2023 | finance.yahoo.com
Bioventix (LON:BVXP) Is Paying Out A Larger Dividend Than Last Year
October 3, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
February 26, 2023 | finance.yahoo.com
Bioventix PLC (LON:BVXP) is largely controlled by institutional shareholders who own 65% of the company
February 15, 2023 | lse.co.uk
Bioventix Plc Share Price (BVXP.GB.PL)
January 20, 2023 | finance.yahoo.com
Bioventix PLC's (LON:BVXP) Stock Is Going Strong: Is the Market Following Fundamentals?
January 4, 2023 | uk.news.yahoo.com
Best British small-cap stocks to buy for January
December 16, 2022 | finance.yahoo.com
Estimating The Intrinsic Value Of Bioventix PLC (LON:BVXP)
December 2, 2022 | finance.yahoo.com
We Discuss Why Bioventix PLC's (LON:BVXP) CEO May Deserve A Higher Pay Packet
November 18, 2022 | finance.yahoo.com
Bioventix (LON:BVXP) shareholders have earned a 12% CAGR over the last five years
October 25, 2022 | finance.yahoo.com
Does Bioventix (LON:BVXP) Deserve A Spot On Your Watchlist?
September 18, 2022 | finance.yahoo.com
Bioventix PLC (LON:BVXP) is favoured by institutional owners who hold 68% of the company
September 14, 2022 | uk.finance.yahoo.com
Bioventix Plc - Trading Update & Notice of Results
August 13, 2022 | finance.yahoo.com
Is Bioventix PLC's (LON:BVXP) Recent Stock Performance Influenced By Its Financials In Any Way?
July 19, 2022 | morningstar.com
Bioventix PLC - Stock Quote BVXP
July 9, 2022 | finance.yahoo.com
Calculating The Intrinsic Value Of Bioventix PLC (LON:BVXP)
July 6, 2022 | finance.yahoo.com
Bioventix PLC (BVXP.L)
June 1, 2022 | finance.yahoo.com
Bioventix (LON:BVXP) shareholders have earned a 18% CAGR over the last five years
May 4, 2022 | uk.finance.yahoo.com
Bioventix Plc - Director Dealing
April 11, 2022 | finance.yahoo.com
What Percentage Of Bioventix PLC (LON:BVXP) Shares Do Insiders Own?
March 29, 2022 | lse.co.uk
Bioventix hikes interim dividend after revenue falls
See More Headlines
Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

BVXP Company Calendar

Last Earnings
3/30/2020
Today
10/03/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Cannabis
Sector
Medical
Current Symbol
LON:BVXP
CUSIP
N/A
CIK
N/A
Web
www.bioventix.com
Phone
+44-1252-728001
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
GBX 1.60
Trailing P/E Ratio
2,415.63
Forward P/E Ratio
22.24
P/E Growth
N/A
Net Income
£8.42 million
Net Margins
65.33%
Pretax Margin
N/A
Return on Equity
83.36%
Return on Assets
56.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.56
Quick Ratio
5.50

Sales & Book Value

Annual Sales
£12.88 million
Price / Sales
15.66
Cash Flow
GBX 125.13 per share
Price / Cash Flow
30.89
Book Value
GBX 201 per share
Price / Book
19.23

Miscellaneous

Outstanding Shares
5,220,000
Free Float
N/A
Market Cap
£201.75 million
Optionable
Not Optionable
Beta
0.41
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Peter John Harrison MA (Age 65)
    CEO & Director
    Comp: $249.89k
  • Mr. Bruce Edward Heath Hiscock (Age 65)
    CFO & Director
    Comp: $81k

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













BVXP Stock - Frequently Asked Questions

How have BVXP shares performed in 2023?

Bioventix's stock was trading at GBX 3,990 on January 1st, 2023. Since then, BVXP stock has decreased by 3.1% and is now trading at GBX 3,865.
View the best growth stocks for 2023 here.

How were Bioventix's earnings last quarter?

Bioventix PLC (LON:BVXP) issued its quarterly earnings results on Monday, March, 30th. The biotechnology company reported $69.28 EPS for the quarter. Bioventix had a trailing twelve-month return on equity of 83.36% and a net margin of 65.33%.

How often does Bioventix pay dividends? What is the dividend yield for Bioventix?

Bioventix announced a dividend on Monday, March 27th. Investors of record on Thursday, April 6th will be paid a dividend of GBX 62 per share on Friday, April 21st. This represents a yield of 1.62%. The ex-dividend date of this dividend is Thursday, April 6th. The official announcement can be accessed at this link.
Read our dividend analysis for BVXP.

Is Bioventix a good dividend stock?

Bioventix (LON:BVXP) pays an annual dividend of GBX 136 per share and currently has a dividend yield of 3.58%. The dividend payout ratio is 8,500.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for BVXP.

What other stocks do shareholders of Bioventix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioventix investors own include Lancashire (LRE), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Entain PLC (GVC.L) (GVC), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS).

What is Bioventix's stock symbol?

Bioventix trades on the London Stock Exchange (LON) under the ticker symbol "BVXP."

How do I buy shares of Bioventix?

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Bioventix's stock price today?

One share of BVXP stock can currently be purchased for approximately GBX 3,865.

How much money does Bioventix make?

Bioventix (LON:BVXP) has a market capitalization of £201.75 million and generates £12.88 million in revenue each year. The biotechnology company earns £8.42 million in net income (profit) each year or GBX 1.60 on an earnings per share basis.

How can I contact Bioventix?

Bioventix's mailing address is 7 Romans Business Park, East Street, FARNHAM, GU9 7SX, United Kingdom. The official website for the company is www.bioventix.com. The biotechnology company can be reached via phone at +44-1252-728001.

This page (LON:BVXP) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -